Homozygous but not heterozygous sporadic loss of <i>Pten</i> resulted in rapid acceleration of tumor growth and end-stage disease by 40 days, compared to ~25% survival in control SmoM2 mice at 100 days. The gene discussed is PTEN; the disease is neoplasm.